Photocure ASA: Blue Light Flexible Cystoscopy with Cysview® Phase 3 study: New data presented at Society of Urological Oncology
Oslo, Norway, December 1, 2017 Photocure ASA (OSE: PHO) announced today that more detailed data from the Phase 3 study data was presented at the prestigious Society of Urologic Oncology, Annual Meeting November 29 - December 01, 2017 in Washington D.C., USA. Four separate posters were presented, including one using patient reported outcomes (PRO) data from this study demonstrated the positive impact of Cysview on patient Quality of Life. The plenary presentation titled "Efficacy and Safety of Flexible Blue Light Cystoscopy with Hexaminolevinulate (HAL) in the Surveillance of Bladder